• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高活性潜在抗结核药物:3-(4-烷基苯基)-4-硫代-2H-1,3-苯并恶嗪-2(3H)-酮和在B环上被卤素取代的3-(4-烷基苯基)-2H-1,3-苯并恶嗪-2,4(3H)-二酮

Highly active potential antituberculotics: 3-(4-alkylphenyl)-4-thioxo-2H-1,3-benzoxazine-2(3H)-ones and 3-(4-alkylphenyl)-2H-1,3-benzoxazine-2,4(3H)-dihiones substituted in ring-B by halogen.

作者信息

Waisser Karel, Matyk Josef, Kunes Jirí, Dolezal Rafael, Kaustová Jarmila, Dahse Hans-Martin

机构信息

Department of Inorganic and Organic Chemistry, Charles University in Prague, Faculty of Pharmacy in Hradec Králové, Hradec Králové, Czech Republic.

出版信息

Arch Pharm (Weinheim). 2008 Dec;341(12):800-3. doi: 10.1002/ardp.200800004.

DOI:10.1002/ardp.200800004
PMID:19006090
Abstract

A series of 6-chloro-3-(4-alkylphenyl)-4-thioxo-2H-1,3-benzoxazine-2(3H)-ones, 7-chloro-3-(4-alkylphenyl)-4-thioxo-2H-1,3-benzoxazine-2(3H)-ones, 6-bromo-3-(4-alkylphenyl)-4-thioxo-2H-1,3-benzoxazine-2(3H)-ones, 6,8-dibromo-3-(4-alkylphenyl)-4-thioxo-2H-1,3-benzoxazine-2(3H)-ones, 6-chloro-3-(4-alkylphenyl)-2H-1,3-benzoxazine-2,4(3H)-dithiones, 7-chloro-3-(4-alkylphenyl)-2H-1,3-benzoxazine-2,4(3H)-dithiones, 6-bromo-3-(4-alkylphenyl)-2H-1,3-benzoxazine-2,4(3H)-dithiones and 6,8-dibromo-3-(4-alkylphenyl)-2H-1,3-benzoxazine-2,4(3H)-dithiones was synthesized. The compounds exhibited in-vitro activity against Mycobacterium tuberculosis, M. kansasii (two strains), and M. avium. 6-bromo-3-(4-propylphenyl)-4-thioxo-2H-1,3-benzoxazin-2(3H)-one and 6-bromo-3-(4-propylphenyl)-2H-1,3-benzoxazin-2,4(3H)-dithione are the most active compounds against M. tuberculosis. The activity is similar to isoniazid (INH). The compounds under study have a broad spectrum of activity against potential pathogenic strains. The replacement of the oxo group by thioxo group of 3-(4-alkylphenyl)-2H-1,3-benzoxazine-2,4(3H)-diones often led to an improvement in the antimycobacterial activity against M. tuberculosis.

摘要

合成了一系列6-氯-3-(4-烷基苯基)-4-硫代-2H-1,3-苯并恶嗪-2(3H)-酮、7-氯-3-(4-烷基苯基)-4-硫代-2H-1,3-苯并恶嗪-2(3H)-酮、6-溴-3-(4-烷基苯基)-4-硫代-2H-1,3-苯并恶嗪-2(3H)-酮、6,8-二溴-3-(4-烷基苯基)-4-硫代-2H-1,3-苯并恶嗪-2(3H)-酮、6-氯-3-(4-烷基苯基)-2H-1,3-苯并恶嗪-2,4(3H)-二硫酮、7-氯-3-(4-烷基苯基)-2H-1,3-苯并恶嗪-2,4(3H)-二硫酮、6-溴-3-(4-烷基苯基)-2H-1,3-苯并恶嗪-2,4(3H)-二硫酮和6,8-二溴-3-(4-烷基苯基)-2H-1,3-苯并恶嗪-2,4(3H)-二硫酮。这些化合物对结核分枝杆菌、堪萨斯分枝杆菌(两株)和鸟分枝杆菌具有体外活性。6-溴-3-(4-丙基苯基)-4-硫代-2H-1,3-苯并恶嗪-2(3H)-酮和6-溴-3-(4-丙基苯基)-2H-1,3-苯并恶嗪-2,4(3H)-二硫酮是对结核分枝杆菌活性最强的化合物。其活性与异烟肼(INH)相似。所研究的化合物对潜在致病菌株具有广泛的活性。3-(4-烷基苯基)-2H-1,3-苯并恶嗪-2,4(3H)-二酮的氧代基团被硫代基团取代通常会导致对结核分枝杆菌的抗分枝杆菌活性提高。

相似文献

1
Highly active potential antituberculotics: 3-(4-alkylphenyl)-4-thioxo-2H-1,3-benzoxazine-2(3H)-ones and 3-(4-alkylphenyl)-2H-1,3-benzoxazine-2,4(3H)-dihiones substituted in ring-B by halogen.高活性潜在抗结核药物:3-(4-烷基苯基)-4-硫代-2H-1,3-苯并恶嗪-2(3H)-酮和在B环上被卤素取代的3-(4-烷基苯基)-2H-1,3-苯并恶嗪-2,4(3H)-二酮
Arch Pharm (Weinheim). 2008 Dec;341(12):800-3. doi: 10.1002/ardp.200800004.
2
Highly active antimycobacterial derivatives of benzoxazine.具有高抗分枝杆菌活性的苯并恶嗪衍生物。
Bioorg Med Chem. 2010 Dec 1;18(23):8178-87. doi: 10.1016/j.bmc.2010.10.017. Epub 2010 Oct 19.
3
[New groups of potential antitubercular agents: 3-(4-ethoxythiocarbonylphenyl)-2-H-benzoxazin-2,4(3H)-diones and 3-(4-ethoxythiocarbonylphenyl)-4-thioxy-2H-benzoxazin-2(3H)-ones].新型潜在抗结核药物:3-(4-乙氧基硫代羰基苯基)-2-H-苯并恶嗪-2,4(3H)-二酮和3-(4-乙氧基硫代羰基苯基)-4-硫氧基-2H-苯并恶嗪-2(3H)-酮
Ceska Slov Farm. 2003 Jan;52(1):42-7.
4
A note to the biological activity of benzoxazine derivatives containing the thioxo group.关于含硫杂环的苯并恶嗪衍生物的生物活性的注释。
Eur J Med Chem. 2010 Jul;45(7):2719-25. doi: 10.1016/j.ejmech.2010.02.037. Epub 2010 Feb 20.
5
New groups of antimycobacterial agents: 6-chloro-3-phenyl-4-thioxo-2H-1,3-benzoxazine-2(3H)-ones and 6-chloro-3-phenyl-2H-1,3-benzoxazine-2,4(3H)-dithiones.新型抗分枝杆菌药物:6-氯-3-苯基-4-硫代-2H-1,3-苯并恶嗪-2(3H)-酮和6-氯-3-苯基-2H-1,3-苯并恶嗪-2,4(3H)-二硫酮
Eur J Med Chem. 2000 Jul-Aug;35(7-8):733-41. doi: 10.1016/s0223-5234(00)00174-4.
6
Influence of the replacement of the oxo function with the thioxo group on the antimycobacterial activity of 3-aryl-6,8-dichloro-2H-1,3-benzoxazine-2,4(3H)-diones and 3-arylquinazoline-2,4(1H,3H)-diones.用硫代羰基取代氧代官能团对3-芳基-6,8-二氯-2H-1,3-苯并恶嗪-2,4(3H)-二酮和3-芳基喹唑啉-2,4(1H,3H)-二酮抗分枝杆菌活性的影响。
Farmaco. 2001 Oct;56(10):803-7. doi: 10.1016/s0014-827x(01)01134-x.
7
The oriented development of antituberculotics (Part II): halogenated 3-(4-alkylphenyl)-1,3-benzoxazine-2,4-(3H)-diones.抗结核药物的定向开发(第二部分):卤代3-(4-烷基苯基)-1,3-苯并恶嗪-2,4-(3H)-二酮
Arch Pharm (Weinheim). 2007 May;340(5):264-7. doi: 10.1002/ardp.200600002.
8
[Antimicrobial salicylanilides and 3-phenyl-2H-1,3-benzoxazine-2,4(3H)-diones].[抗微生物水杨酰苯胺类和3-苯基-2H-1,3-苯并恶嗪-2,4(3H)-二酮]
Ceska Slov Farm. 2001 May;50(3):148-52.
9
High active potential antimycobacterial agents against Mycobacterium avium.针对鸟分枝杆菌的高活性抗分枝杆菌药物。
Ceska Slov Farm. 2012 Jun;61(3):127-9.
10
The oriented development of antituberculotics: salicylanilides.抗结核药物的定向开发:水杨酰苯胺类
Arch Pharm (Weinheim). 2006 Nov;339(11):616-20. doi: 10.1002/ardp.200600093.

引用本文的文献

1
Synthesis of 3,5-isoxazolidinediones and 1H-2,3-benzoxazine-1,4(3H)-diones from aliphatic oximes and dicarboxylic acid chlorides.由脂肪族肟和二羧酸氯化物合成3,5-异恶唑烷二酮和1H-2,3-苯并恶嗪-1,4(3H)-二酮
J Org Chem. 2014 Apr 4;79(7):2874-82. doi: 10.1021/jo402708j. Epub 2014 Mar 21.